Biosimilar therapies in inflammatory bowel disease: should we care about patient profile?

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1-3
Number of pages3
JournalExpert Review of Clinical Immunology
DOIs
Publication statusAccepted/In press - Feb 5 2016

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

@article{bc0ad4fca68c4c27883e7a731116411e,
title = "Biosimilar therapies in inflammatory bowel disease: should we care about patient profile?",
author = "Gionata Fiorino and Maria Fazio and Silvio Danese",
year = "2016",
month = "2",
day = "5",
doi = "10.1586/1744666X.2016.1141050",
language = "English",
pages = "1--3",
journal = "Expert Review of Clinical Immunology",
issn = "1744-666X",
publisher = "Expert Reviews Ltd.",

}

TY - JOUR

T1 - Biosimilar therapies in inflammatory bowel disease

T2 - should we care about patient profile?

AU - Fiorino, Gionata

AU - Fazio, Maria

AU - Danese, Silvio

PY - 2016/2/5

Y1 - 2016/2/5

UR - http://www.scopus.com/inward/record.url?scp=84958062800&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958062800&partnerID=8YFLogxK

U2 - 10.1586/1744666X.2016.1141050

DO - 10.1586/1744666X.2016.1141050

M3 - Article

AN - SCOPUS:84958062800

SP - 1

EP - 3

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

ER -